Growing urinary tract infections amongst population is expected to drive the growth of India norfloxacin market during the forecast period.
According to TechSci Research report, “India Norfloxacin Market By Product Type (Prescription v/s OTC), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Eye drops, Syrup, Ointment and Injection), By Route of Administration (Oral, Intravenous, Topical, Ophthalmic), By Distribution Channel (Online v/s Offline), By Application (Urinary tract Infections, Gynaecological Infections, Bladder Infections, Inflammation Of The Prostate Gland, Gonorrhoea And Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2027”, the India norfloxacin market is expected to grow at a significant pace during the forecast period on account of growing high prevalence of chronic diseases in the country. Norfloxacin is a broad-spectrum antibiotic agent that is known to be effective against various gram-positive and gram-negative bacterial species. Increase in number of pharmaceutical manufacturers in the country is creating growth opportunities for norfloxacin market over the forecast period. Development of novel combination therapies by R&D processes for treating antibiotic-resistant microbial infections is expected to fuel the market growth through FY2027. Favorable government policies is expected to drive the market growth in the forthcoming years. However, development of drug-resistant strains can restrict the market growth over the next few years. Norfloxacin is ineffective against viral infections. Also, the side effects associated with the use of antibiotic such as gastrointestinal effects including nausea, vomiting, and diarrhea, as well as headache and insomnia, can act as major impediments to the growth of India norfloxacin market during the forecast period.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “India Norfloxacin Market.” https://www.techsciresearch.com/report/india-norfloxacin-market/7316.html
The India norfloxacin market is segmented based on product type, source, form, route of administration, distribution channel, application, end user, company, and region. Based on distribution channel, the market can be fragmented into online v/s offline. The offline channel is expected to dominate the market which is attributable to several benefits it offers such as consumers can inspect and examine merchandise by themselves. The online segment is also expected to register significant growth over the next few years. This can be ascribed to the development of numerous online pharmacies and doorstep drug delivery in the country.
Alkem Laboratories Ltd., Aristo Pharmaceuticals Ltd., Hetero Healthcare Ltd., Taurus Laboratories Pvt. Ltd., Alembic Ltd., Ranbaxy Laboratories Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., IPCA Laboratories Ltd., Emcure Pharmaceuticals Ltd., and others are some of the leading players operating in India norfloxacin market. The key market players operating in the market are using organic strategies such as product launches, mergers and acquisitions, research collaborations, joint ventures to boost their market share and to expand their geographic reach. Along with this, supportive policy for the pharmaceutical industry is anticipated to aid the current market of Norfloxacin.
Download Free Sample Report@ https://www.techsciresearch.com/sample-report.aspx?cid=7316
Customers can also request for 10% free customization on this report.
“India norfloxacin market is expected to witness significant growth in the next 5 years on account of increased number of bacterial infections. Furthermore, continuous research and development to exploit the drugs full potential is further expected to fuel the market growth through FY2027. Also, the drug is also used to treat gynaecological infections which is another key factor that is expected to create lucrative opportunities for the market growth over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Norfloxacin Market By Product Type (Prescription v/s OTC), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Eye drops, Syrup, Ointment and Injection), By Route of Administration (Oral, Intravenous, Topical, Ophthalmic), By Distribution Channel (Online v/s Offline), By Application (Urinary tract Infections, Gynaecological Infections, Bladder Infections, Inflammation Of The Prostate Gland, Gonorrhoea And Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2027”, has evaluated the future growth potential of India norfloxacin market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India norfloxacin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com/